Presentation is loading. Please wait.

Presentation is loading. Please wait.

Judie Finesilver MRPharmS e-Business Pharmacist Commercial Medicines Unit, Department of Health 07785 573 914 Update on barcodes.

Similar presentations


Presentation on theme: "Judie Finesilver MRPharmS e-Business Pharmacist Commercial Medicines Unit, Department of Health 07785 573 914 Update on barcodes."— Presentation transcript:

1 Judie Finesilver MRPharmS e-Business Pharmacist Commercial Medicines Unit, Department of Health Update on barcodes & medicines-associated issues in NHS February 23 rd 2012 Franklin Room, IBM United Kingdom Limited, 76/78 Upper Ground,

2 What’s the current message ? NHS dm+d GS1 EU Falsified Medicines Directive Projects from CMU

3 NHS Dictionary of Medicines and Devices – dm+d Website Name, strength, form of a medicine No ambiguity Enter the GTIN

4

5 No supply chain informaton.. No GTIN

6 GTIN Global Trader Item Number GTIN- used to be known as EAN Managed by GS1- Global Standards 1 Population of GTIN field currently ~ 20% Working with BSA to appear in the browser

7 Link between clinical and supply chain will support patient safety Example

8 Similar looking product- very different clinical action

9

10 Wrong label attached to product

11

12

13

14

15 What else could the barcode carry? Newer and cleverer carriers. QR code : 2D data matrix code Quick Response Code

16 EU Falsified Medicines Directive ults_on_Falsified_Medicines_Directive/71100

17 Safety Features? Tamper-Evident Seal Unique Identifier

18 Process All POMs to be included and Medicines to be risk assessed for exclusion where the product is a POM or for inclusion where the product is a prescription medicine. Risk assessments proposed to be based on cost, volume, risk to health.

19 Issues Cross industry issues : secondary care / homecare – who has responsibility for tracking and recording of codes? Issues in primary care: connectivity and networking issues raised – verification response time needs to be short

20 Discussion needed! What are the most appropriate step(s) in the process for identification to happen ? – Point of dispensing only Point of dispensing plus random points along the supply chain Point of dispensing plus systematically along the supply chain Who is going to pay for this? What happens if legislation changes? Does this need enforcing – won’t happen otherwise?

21 Pan European issues: Europe are seeking harmonisation across Europe on standards, scanning mechanism (GS1 Or similar?) and repository approach When importing, products will need to be checked out of one countries repository and into another Who will hold the verification repository? options include: Centralised Europe repository, National Repository or a stakeholder owned repository (joint pharmacy and industry associations via not for profit organization). Complications include some countries may want to collaborate on setting up joint repositories and some may wish autonomy).

22 Benefits Patient safety – the most important Efficiency improvements (though wholesalers voiced concerns over additional workload if scanning each pack was imposed) Aid investigation of errors Aid product recall process Having a unique identifier will ensure counterfeiters can’t produce large batches of product – less cost effective Companies that adopt 2D will be seen as having a differentiating factor when UK making purchasing decisions

23 Risk manufacturers not willing to adopt will leave the UK market – what impact will that have on UK supply chain?

24 Summary!

25 Current Projects for CMU KPI reports- JAC v4.47 and Crystal X1 Ascrbe v8 Stockholding Report- 2 addresses Homecare

26 Want to identify the homecare spend Request to hospital pharmacy to include the word (Home) in the supplier names And possibly to include the word (Home) in the product Description. Onerous Difficult Are you affected?

27 To Summarise NHS dm+d- add product into Data base GS1- not for profit global organisation- manage coding carriers EU Falsified Medicines Directive- tamper evidence and unique identification of product. Risk assessment for opt-out for all POMs for opt-in for all Ps Projects for CMU- KPIs; Stockholding; Homecare

28 Judie Finesilver MRPharmS e-Business Pharmacist Commercial Medicines Unit, Department of Health Update on barcodes & medicines-associated issues in NHS February 23 rd 2012 Franklin Room, IBM United Kingdom Limited, 76/78 Upper Ground,


Download ppt "Judie Finesilver MRPharmS e-Business Pharmacist Commercial Medicines Unit, Department of Health 07785 573 914 Update on barcodes."

Similar presentations


Ads by Google